References
- Cramer S F, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990; 94: 435–438
- Lepine L A, Hillis S D, Marchbanks P A, Koonin L M, Morrow B, Kieke B A, Wilcox L S. Hysterectomy surveillance – United States, 1980–1993. MMWR CDC Surveill Summ 1997; 46: 1–15
- Ravina J H, Herbreteau D, Ciraru-Vigneron N, Bouret J M, Houdart E, Aymard A, Merland J J. Arterial embolisation to treat uterine myomata. Lancet 1995; 346: 671–672
- Walker W J, Pelage J P. Uterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging follow up. BJOG 2002; 109: 1262–1272
- Volkers N A, Hehenkamp W J, Birnie E, Ankum W M, Reekers J A. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. Am J Obstet Gynecol 2007; 196: 519.e1–519.e11
- Edwards R D, Moss J G, Lumsden M A, Wu O, Murray L S, Twaddle S, Murray G D, Committee of the Randomized Trial of Embolization versus Surgical Treatment for Fibroids. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med 2007; 25: 360–370
- Lethaby A, Vollenhoven B, Sowter M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev 2001; 2: CD000547
- Phillips D R. GnRH analogs and uterine artery embolization. J Am Assoc Gynecol Laparosc 1999; 6: 368
- Burbank F, Hutchins F L, Jr. Uterine artery occlusion by embolization or surgery for the treatment of fibroids: a unifying hypothesis-transient uterine ischemia. J Am Assoc Gynecol Laparosc 2000; 7(4 Suppl)S1–S49
- Spies J B. Uterine artery embolization for fibroids: understanding the technical causes of failure. J Vasc Interv Radiol 2003; 14: 11–14
- Jelkmann W. Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem 2001; 47: 617–623
- Hague S, Zhang L, Oehler M K, Manek S, MacKenzie I Z, Bicknell R, Rees M C. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density. Clin Cancer Res 2000; 6: 2808–2814
- Huang R, Lin Y, Shi Q, Flowers L, Ramachandran S, Horowitz I R, Parthasarathy S, Huang R P. Enhanced protein profiling arrays with ELISA-based amplification for high-throughput molecular changes of tumor patients' plasma. Clin Cancer Res 2004; 10: 598–609
- Takeda T, Osuga K, Morishige K, Tasaka K, Nakamura H, Murata Y. Changes of plasma vascular endothelial growth factor level after uterine artery embolisation for leiomyomata. Br J Obstet Gynecol 2005; 112: 1437–1439
- Di Lieto A, De Falco M, Pollio F, Mansueto G, Salvatore G, Somma P, Ciociola F, De Rosa G, Staibano S. Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas. J Soc Gynecol Investig 2005; 12: 123–128